Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in ...

Companies that excel at strategic foresight are able to systematically track both predictable future events and true unknowns ...

Purdue is committed to building a better world — together. In pursuit of this commitment, the following initiatives were created to guide our everyday efforts and play a key role in defining our ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...

Proven financial and strategic leader with over two decades of experience driving organizational growth, operational ...

Jan 05, 2026 // Heading into 2026, the geopolitical and global governance short–term outlooks look perilous. Yet many ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”) today announced that CEO Fabio Chianelli has published ...

Prime Minister Kim Unveils Ministry of Planning and Budget Signboard New ministry split from Economy and Finance to handle ...

Mowi has entered into a strategic and industrial partnership agreement with Skretting/Nutreco where Mowi produces feed based ...